Versant Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.55M | Sell |
12,085
-100
| -0.8% | -$11.7K | 0.14% | 86 |
|
|
2026
Q1 | $1.47M | Buy |
12,185
+3,862
| +46% | +$446K | 0.14% | 88 |
|
|
2025
Q4 | $876K | Buy |
8,323
+1,851
| +29% | +$174K | 0.11% | 106 |
|
|
2025
Q3 | $543K | Buy |
6,472
+3,134
| +94% | +$258K | 0.07% | 177 |
|
|
2025
Q2 | $264K | Sell |
3,338
-5,228
| -61% | -$416K | 0.04% | 370 |
|
|
2025
Q1 | $769K | Buy |
8,566
+6,221
| +265% | +$581K | 0.13% | 95 |
|
|
2024
Q4 | $233K | Buy |
2,345
+131
| +6% | +$13.5K | 0.05% | 156 |
|
|
2024
Q3 | $251K | Buy |
2,214
+373
| +20% | +$44.3K | 0.06% | 136 |
|
|
2024
Q2 | $228K | Buy |
1,841
+922
| +100% | +$119K | 0.06% | 128 |
|
|
2024
Q1 | $121K | Hold |
919
| – | – | 0.03% | 169 |
|
|
2023
Q4 | $100K | Sell |
919
-1
| -0.1% | -$104 | 0.03% | 189 |
|
|
2023
Q3 | $94.7K | Sell |
920
-6
| -0.6% | -$647 | 0.03% | 184 |
|
|
2023
Q2 | $107K | Buy |
926
+95
| +11% | +$10.8K | 0.03% | 177 |
|
|
2023
Q1 | $88.4K | Hold |
831
| – | – | 0.03% | 184 |
|
|
2022
Q4 | $92.2K | Sell |
831
-3
| -0.4% | -$307 | 0.03% | 162 |
|
|
2022
Q3 | $72K | Hold |
834
| – | – | 0.03% | 177 |
|
|
2022
Q2 | $76K | Hold |
834
| – | – | 0.03% | 177 |
|
|
2022
Q1 | $68K | Sell |
834
-7
| -0.8% | -$552 | 0.02% | 207 |
|
|
2021
Q4 | $64K | Hold |
841
| – | – | 0.02% | 207 |
|
|
2021
Q3 | $63K | Sell |
841
-52
| -6% | -$3.96K | 0.02% | 191 |
|
|
2021
Q2 | $69K | Sell |
893
-967
| -52% | -$71.9K | 0.03% | 176 |
|
|
2021
Q1 | $137K | Buy |
1,860
+3
| +0.2% | +$221 | 0.05% | 130 |
|
|
2020
Q4 | $144K | Sell |
1,857
-11
| -0.6% | -$841 | 0.06% | 116 |
|
|
2020
Q3 | $147K | Hold |
1,868
| – | – | 0.07% | 113 |
|
|
2020
Q2 | $137K | Sell |
1,868
-13
| -0.7% | -$979 | 0.06% | 115 |
|
|
2020
Q1 | $138K | Sell |
1,881
-242
| -11% | -$19K | 0.07% | 99 |
|
|
2019
Q4 | $184K | Sell |
2,123
-23
| -1% | -$1.89K | 0.09% | 86 |
|
|
2019
Q3 | $172K | Sell |
2,146
-14
| -0.6% | -$1.12K | 0.08% | 89 |
|
|
2019
Q2 | $172K | Sell |
2,160
-708
| -25% | -$54.2K | 0.08% | 91 |
|
|
2019
Q1 | $227K | Sell |
2,868
-46
| -2% | -$3.44K | 0.1% | 87 |
|
|
2018
Q4 | $212K | Hold |
2,914
| – | – | 0.1% | 88 |
|
|
2018
Q3 | $197K | Sell |
2,914
-107
| -4% | -$6.82K | 0.08% | 94 |
|
|
2018
Q2 | $174K | Buy |
3,021
+50
| +2% | +$2.82K | 0.07% | 103 |
|
|
2018
Q1 | $154K | Sell |
2,971
-535
| -15% | -$28.9K | 0.06% | 113 |
|
|
2017
Q4 | $188K | Buy |
3,506
+387
| +12% | +$21.5K | 0.08% | 106 |
|
|
2017
Q3 | $190K | Sell |
3,119
-128
| -4% | -$7.76K | 0.1% | 80 |
|
|
2017
Q2 | $198K | Sell |
3,247
-6
| -0.2% | -$365 | 0.11% | 80 |
|
|
2017
Q1 | $197K | Hold |
3,253
| – | – | 0.11% | 80 |
|
|
2016
Q4 | $182K | Sell |
3,253
-204
| -6% | -$11.9K | 0.1% | 82 |
|
|
2016
Q3 | $205K | Buy |
3,457
+23
| +0.7% | +$1.34K | 0.12% | 75 |
|
|
2016
Q2 | $188K | Sell |
3,434
-132
| -4% | -$7.03K | 0.11% | 74 |
|
|
2016
Q1 | $180K | Sell |
3,566
-80
| -2% | -$3.92K | 0.11% | 76 |
|
|
2015
Q4 | $183K | Buy |
+3,646
| New | +$184K | 0.11% | 73 |
|
Other funds holding MRK
LMFP
ATO
AAMU
Versant Capital Management's MRK Position: Q2 2026 in Review
Versant Capital Management reduced its Merck (MRK) stake by 0.82% in Q2 2026, selling an estimated $11.7K and leaving 12,085 shares worth $1.55M. The position accounts for 0.14% of the portfolio, ranked #86.
Versant Capital Management first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. 1,120 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Versant Capital Management held 12,085 shares of Merck worth $1.55M as of Q2 2026.
- Versant Capital Management sold 100 Merck shares in Q2 2026, an estimated $11.7K.
- Merck made up 0.14% of Versant Capital Management's portfolio in Q2 2026, its #86 holding.
- Versant Capital Management first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
- 1,120 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.